Use of <scp>Disease‐Modifying</scp> Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared <scp>Decision‐Making</scp> Between Patients With Cancer and Clinicians-Reference-Cited by-同舟云学术

Use of Disease‐Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision‐Making Between Patients With Cancer and Clinicians

Author:

Singh Namrata¹^ORCID,Grivas Petros²,Makris Una E.³,Suarez‐Almazor Maria E.⁴^ORCID,O'Hare Ann M.⁵,Barton Jennifer L.⁶^ORCID

Affiliation:

1. University of Washington Seattle

2. University of Washington and Fred Hutchinson Cancer Center Seattle

3. University of Texas Southwestern Medical Center Dallas

4. The University of Texas MD Anderson Cancer Center Houston

5. Department of Veterans Affairs Puget Sound Health Care System and University of Washington Seattle

6. Oregon Health and Science University and Department of Veterans Affairs Portland Health Care System Portland

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Wiley

Subject

Rheumatology

Link

Reference18 articles.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献